Other languages BioCorRx Inc.

Equities

BICX

US09073C2052

Market Closed - OTC Markets Other stock markets 10:02:39 24/06/2024 pm IST			5-day change	1st Jan Change
0.49 ^USD	-2.00%		-2.00%	-37.18%

15/05	BioCorRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/04	BioCorRx Inc. Announces Board Resignations	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioCorRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
BioCorRx Inc. Announces Board Resignations	04/04
BioCorRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
BioCorRx Pharmaceuticals Inc. Appoints Kate Devarney to the Board of Directors	08/02
BioCorRx Inc. Announces President Changes	06/01
BioCorRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Biocorrx Inc. Announces Management Changes	03/11
BioCorRx Inc. Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder	15/23/15
BioCorRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
BioCorRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
Insider Buy: Biocorrx	06/23/06
BioCorRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31
BioCorRx Inc. Auditor Raises 'Going Concern' Doubt	31/23/31
BioCorRx Inc. Announces Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial At 4Th Annual NIH HEAL Initiative Investigator Meeting	08/23/08
BioCorRx Inc. Appoints Harsha Murthy as A Member of the Board of Directors	24/23/24
BioCorRx Inc. Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder, Which is Being Developed Under BioCorRx Pharmaceuticals, Inc	19/23/19
BioCorRx Inc. Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United States	07/22/07
BioCorRx Inc. agreed to Spin-Off BioCorRx Pharmaceuticals, Inc.	22/22/22
BioCorRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14
BioCorRx Inc. Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104	13/22/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BioCorRx Inc.

Equities

BICX

US09073C2052

Other languages

Filters